Depakote vs. Aripiprazole: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Depakote and Aripiprazole. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 201,969 people who take Depakote and Aripiprazole, and is updated regularly.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.
What is Aripiprazole?
Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
201,969 people who take Depakote and Aripiprazole are studied.
Drugs being compared in this study:
- Aripiprazole (aripiprazole)
- Depakote (divalproex sodium)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Depakote:
- not at all: 5.17 %
- somewhat: 20.46 %
- moderate: 31.03 %
- high: 29.83 %
- very high: 13.51 %
Aripiprazole:
- not at all: 7.59 %
- somewhat: 24.77 %
- moderate: 30.08 %
- high: 26.02 %
- very high: 11.54 %
Want to compare Depakote with Aripiprazole?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Depakote (52,628 reports)
- Aripiprazole (38,855 reports)
Browse all side effects of Depakote:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on divalproex sodium and aripiprazole (the active ingredients of Depakote and Aripiprazole, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Penis Injury and drugs of ingredients of pregabalin - 2 seconds ago
- Drug interactions of Novalgin and Tresiba - 7 seconds ago
- Drug interactions of Repaglinide and Lorazepam - 12 seconds ago
- Could Lorazepam cause Disseminated Intravascular Coagulation? - 24 seconds ago
- Could Infed cause Dizziness Aggravated? - 34 seconds ago
- Could Lipitor cause Eye Infection? - 36 seconds ago
- Carotid Artery Occlusion and drugs of ingredients of montelukast sodium - 37 seconds ago
- Drug interactions of Rituxan and Xeljanz Xr - a minute ago
- Respiratory Distress and drugs of ingredients of triamcinolone acetonide - a minute ago
- Could Flomax cause Atrioventricular Block Complete? - a minute ago